AHP BENEFIX RECOMBINANT FACTOR IX PRICED AT 8 [cents]/UNIT PREMIUM TO PLASMA-DERIVED PRODUCT; GENETICS INSTITUTE SHIPS FEB. 12; LABEL SPECIFIES DOSE ADJUSTMENT
Executive Summary
Genetics Institute is selling BeneFix recombinant human factor IX at an average wholesale price of $1.18 per unit, an eight cent per unit premium to the plasma-derived factor IX products AlphaNine (Alpha Therapeutic) and Mononine (Centeon). BeneFix is available in single-dose vials of 250, 500 or 1,000 international units.